Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension
| Status: | Completed |
|---|---|
| Conditions: | High Blood Pressure (Hypertension), Ocular |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Ophthalmology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | May 2014 |
| End Date: | December 2014 |
This efficacy and safety study will evaluate LUMIGAN® .01 (bimatoprost 0.01%) alone compared
to TRAVATAN Z® (travoprost 0.004%) and TIMOLOL GFS, 0.5% (timolol 0.5% ophthalmic gel
forming solution) in patients who require IOP lowering therapy.
to TRAVATAN Z® (travoprost 0.004%) and TIMOLOL GFS, 0.5% (timolol 0.5% ophthalmic gel
forming solution) in patients who require IOP lowering therapy.
Inclusion Criteria:
- Ocular hypertension or glaucoma that requires treatment with medication
- Have a best corrected visual acuity (BCVA) of 20/100 or better in both eyes
Exclusion Criteria:
- History of LASIK, LASEK, RK, and/or PRK in the study eye(s)
- History of any intraocular surgery or glaucoma laser surgery in the study eye(s)
within 3 months
- Use of topical, periorbital, intravitreal or systemic steroid within 3 months or
expected use during the course of study
We found this trial at
1
site
Click here to add this to my saved trials
